Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp

Bullboard Posts

Comment by jewel9mon Feb 15, 2019 7:39pm

74 Views

Post# 29373838

RE:RE:RE:Same old same old...

That explains why House 124 (Questrade) has sold the last 3 news releases in a row. Have consistentaly sold from .09cents to .135 cents. They just got a sweet deal and 3 year .16cent warrants???

Like Wex said all we needed is 500k and not .16 cent warrants for 3 years. Complete BS!!!

Expect a drop and then it will rebound and see what the news will be. Has to be high chance of a deal or the ones in the know (PP investors) would not have taken the PP.

Really this sould be illegal. Knowing that a PP is coming and selling on news. GOOD OLD VENTURE.

Bullboard Posts

Investors eye Australian gold mining projects amid promising developments